(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.

The three biggest winners today are ADC SIIC, PETROLIA, and ASETEK.

Financial Asset	Price	Change	Updated (EST)
ADC SIIC (ALDV.PA)	0.07	25.44%	2023-09-19 12:45:32
PETROLIA (PSE.OL)	4.70	9.81%	2023-09-19 12:42:24
ASETEK (ASTK.OL)	8.34	8.03%	2023-09-19 12:25:34
SCANA (SCANA.OL)	2.39	6.71%	2023-09-19 12:43:09
POLARIS MEDIA (POL.OL)	53.00	6%	2023-09-19 12:42:34
ALMUNDA PRO NV (AMUND.AS)	1.26	5.88%	2023-09-19 12:00:26
VISTIN PHARMA (VISTN.OL)	24.10	5.7%	2023-09-19 12:44:39
NORTHERN DRILLING (NODL.OL)	28.00	5.66%	2023-09-19 12:41:45
ULTIMOVACS (ULTI.OL)	76.90	5.63%	2023-09-19 12:44:35
SOLSTAD OFFSHORE (SOFF.OL)	26.00	5.35%	2023-09-19 12:43:38

The three biggest losers today are ADOCIA, VALUE8 CUM PREF, and ATLANTIC SAPPHIRE.

Financial Asset	Price	Change	Updated (EST)
ADOCIA (ADOC.PA)	7.91	-12.69%	2023-09-19 12:45:34
VALUE8 CUM PREF (PREVA.AS)	4.42	-9.8%	2023-09-19 12:04:51
ATLANTIC SAPPHIRE (ASA.OL)	1.81	-9.5%	2023-09-19 12:25:38
ONWARD MEDICAL (ONWD.BR)	3.73	-8.8%	2023-09-19 12:21:05
NAPATECH (NAPA.OL)	10.00	-7.41%	2023-09-19 12:41:25
AFFLUENT MEDICAL (AFME.PA)	1.18	-5.6%	2023-09-19 12:45:48
CABKA (CABKA.AS)	7.46	-5.57%	2023-09-19 12:01:15
ALD (ALD.PA)	8.01	-5.32%	2023-09-19 12:46:00
MOREFIELD GROUP (MORE.AS)	0.32	-4.76%	2023-09-19 12:03:13
EQVA (EQVA.OL)	2.82	-4.73%	2023-09-19 12:27:04

Winners today

1. ADC SIIC (ALDV.PA)

25.44% Price Change

Alliance Developpement Capital SIIC (ADC SIIC) is a publicly owned real estate investment firm. The firm specializes in owning and managing residential real estate properties. It primarily invests in properties in Paris and its suburbs. The firm was formerly known as AD Capital SA. Alliance Developpement Capital is based in Saint-Josse-Ten-Noode, Belgium.

CAC 40 ended the session with ADC SIIC rising 25.44% to €0.07 on Tuesday while CAC 40 rose 0.08% to €7,282.12.

Earnings Per Share

As for profitability, ADC SIIC has a trailing twelve months EPS of €-0.01.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1.87%.

Moving Average

ADC SIIC’s worth is higher than its 50-day moving average of €0.07 and higher than its 200-day moving average of €0.07.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ADC SIIC’s stock is considered to be overbought (>=80).

Volatility

ADC SIIC’s last week, last month’s, and last quarter’s current intraday variation average was a negative 10.53%, a negative 3.74%, and a positive 13.36%.

ADC SIIC’s highest amplitude of average volatility was 10.53% (last week), 13.88% (last month), and 13.36% (last quarter).

Volume

Today’s last reported volume for ADC SIIC is 2000 which is 78.23% below its average volume of 9189.

More news about ADC SIIC.

2. PETROLIA (PSE.OL)

9.81% Price Change

Petrolia SE, together with its subsidiaries, sells and rents energy service equipment to energy industry in Norway, rest of Europe, Asia, and Australia. It operates through two segments, Energy and Energy Service. The company engages in the exploration and production of oil and gas, as well as produces hydrogen and ammonia. It also offers drill pipes, test strings and tubing, and other equipment, as well as casing, handling, and auxiliary tools; and equipment inspection and maintenance services. In addition, the company offers casing and tubing running, drilling, and make and brake services. It serves energy companies, drilling contractors, and energy service companies. The company was formerly known as Petrolia E&P Holdings SE and changed its name to Petrolia SE in January 2013. Petrolia SE was founded in 1997 and is based in Limassol, Cyprus.

Oslo Børs Benchmark Index_GI ended the session with PETROLIA rising 9.81% to €4.70 on Tuesday while Oslo Børs Benchmark Index_GI rose 0.1% to €1,301.38.

Earnings Per Share

As for profitability, PETROLIA has a trailing twelve months EPS of kr0.04.

PE Ratio

PETROLIA has a trailing twelve months price to earnings ratio of 117.5. Meaning, the purchaser of the share is investing kr117.5 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1.9%.

Yearly Top and Bottom Value

PETROLIA’s stock is valued at kr4.70 at 22:40 EST, way below its 52-week high of kr5.56 and way above its 52-week low of kr3.48.

Revenue Growth

Year-on-year quarterly revenue growth grew by 4.9%, now sitting on 55.5M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, PETROLIA’s stock is considered to be oversold (<=20).

More news about PETROLIA.

3. ASETEK (ASTK.OL)

8.03% Price Change

Asetek A/S, together with its subsidiaries, engages in the designing, developing, and marketing of liquid cooling solutions in Asia, Europe, and the Americas. The company operates through Liquid cooling, Data center and SimSports segments. Its products are used in personal computers, servers, and data centers to provide improved performance, acoustics, and energy efficiency. It serves original equipment manufacturers, resellers, and channel partners. The company was founded in 1997 and is headquartered in Aalborg, Denmark.

Oslo Børs Benchmark Index_GI ended the session with ASETEK jumping 8.03% to €8.34 on Tuesday while Oslo Børs Benchmark Index_GI rose 0.1% to €1,301.38.

Earnings Per Share

As for profitability, ASETEK has a trailing twelve months EPS of kr-0.04.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.33%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ASETEK’s stock is considered to be overbought (>=80).

More news about ASETEK.

4. SCANA (SCANA.OL)

6.71% Price Change

Scana ASA engages in the offshore, energy, and maritime businesses in Norway, rest of European countries, North America, Asia, and internationally. The company offers valve remote control systems and mooring solutions to vessels, rigs, and floating structures serving the shipping, oil and gas, aquaculture, and energy industries. It also engages in the design and integration of electrical power systems, electrical infrastructure, and energy storage systems and control systems; and provides standard and customized containers/module solutions, as well as various types of welded constructions for offshore and onshore projects. In addition, the company is involved in the planning and execution of insulation, scaffolding, and surface treatment services; and rig, capping, equipment support, make and break, IMR lifecycle, welding, and asset integrity management services to drilling industry, as well as offers riser applications to the oil and gas industry. Scana ASA was formerly known as Incus Investor ASA and changed its name to Scana ASA in May 2020. The company was founded in 1646 and is headquartered in Bergen, Norway.

Oslo Børs Benchmark Index_GI ended the session with SCANA jumping 6.71% to €2.39 on Tuesday while Oslo Børs Benchmark Index_GI rose 0.1% to €1,301.38.

Earnings Per Share

As for profitability, SCANA has a trailing twelve months EPS of kr0.05.

PE Ratio

SCANA has a trailing twelve months price to earnings ratio of 47.7. Meaning, the purchaser of the share is investing kr47.7 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.69%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 98.9%, now sitting on 1.28B for the twelve trailing months.

Volatility

SCANA’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.26%, a negative 0.04%, and a positive 2.06%.

SCANA’s highest amplitude of average volatility was 1.26% (last week), 2.24% (last month), and 2.06% (last quarter).

Yearly Top and Bottom Value

SCANA’s stock is valued at kr2.39 at 22:40 EST, under its 52-week high of kr2.59 and way higher than its 52-week low of kr0.96.

More news about SCANA.

5. POLARIS MEDIA (POL.OL)

6% Price Change

Polaris Media ASA operates as a digital media company in Norway and Sweden. The company provides digital advertising services. It also prints corporate and external newspapers, including editorial vouchers, advertising vouchers and newspapers, civil prints, and other magazines/vouchers. In addition, the company distributes newspapers, as well as parcels, mails, and food deliveries. The company is headquartered in Trondheim, Norway.

Oslo Børs Benchmark Index_GI ended the session with POLARIS MEDIA jumping 6% to €53.00 on Tuesday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI rose 0.1% to €1,301.38, following the last session’s downward trend on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, POLARIS MEDIA has a trailing twelve months EPS of kr1.83.

PE Ratio

POLARIS MEDIA has a trailing twelve months price to earnings ratio of 28.96. Meaning, the purchaser of the share is investing kr28.96 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.83%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 2.6%, now sitting on 3.66B for the twelve trailing months.

Yearly Top and Bottom Value

POLARIS MEDIA’s stock is valued at kr53.00 at 22:40 EST, way under its 52-week high of kr72.80 and way higher than its 52-week low of kr47.20.

Moving Average

POLARIS MEDIA’s value is above its 50-day moving average of kr50.12 and higher than its 200-day moving average of kr52.27.

More news about POLARIS MEDIA.

6. ALMUNDA PRO NV (AMUND.AS)

5.88% Price Change

Almunda Professionals N.V., a business and IT consultancy company, provides business services in the financial sector. It offers consultancy services in the areas of regulatory change, digital transformation, information security, and information services. The company was formerly known as Novisource N.V. and changed its name to Almunda Professionals N.V. in August 2021. Almunda Professionals N.V. was founded in 2001 and is based in Amsterdam, the Netherlands.

AEX-Index ended the session with ALMUNDA PRO NV rising 5.88% to €1.26 on Tuesday, after three sequential sessions in a row of losses. AEX-Index fell 0.13% to €734.93, after two sequential sessions in a row of losses, on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, ALMUNDA PRO NV has a trailing twelve months EPS of €0.02.

PE Ratio

ALMUNDA PRO NV has a trailing twelve months price to earnings ratio of 63. Meaning, the purchaser of the share is investing €63 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.17%.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Jul 10, 2023, the estimated forward annual dividend rate is 0.06 and the estimated forward annual dividend yield is 4.51%.

More news about ALMUNDA PRO NV.

7. VISTIN PHARMA (VISTN.OL)

5.7% Price Change

Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. The company was founded in 1969 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with VISTIN PHARMA jumping 5.7% to €24.10 on Tuesday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI jumped 0.1% to €1,301.38, following the last session’s downward trend on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, VISTIN PHARMA has a trailing twelve months EPS of kr0.33.

PE Ratio

VISTIN PHARMA has a trailing twelve months price to earnings ratio of 73.03. Meaning, the purchaser of the share is investing kr73.03 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.32%.

Yearly Top and Bottom Value

VISTIN PHARMA’s stock is valued at kr24.10 at 22:40 EST, below its 52-week high of kr25.10 and way above its 52-week low of kr11.25.

Volatility

VISTIN PHARMA’s last week, last month’s, and last quarter’s current intraday variation average was 0.12%, 0.11%, and 2.61%.

VISTIN PHARMA’s highest amplitude of average volatility was 2.57% (last week), 2.65% (last month), and 2.61% (last quarter).

Moving Average

VISTIN PHARMA’s value is above its 50-day moving average of kr22.73 and way higher than its 200-day moving average of kr19.49.

More news about VISTIN PHARMA.

8. NORTHERN DRILLING (NODL.OL)

5.66% Price Change

Northern Drilling Ltd. operates as an offshore drilling contractor to the oil and gas industry. The company primarily engages in acquiring and operating offshore drilling assets, as well as involved in drilling in ultra-deep water environments. Northern Drilling Ltd. was incorporated in 2017 and is based in Hamilton, Bermuda.

Oslo Børs Benchmark Index_GI ended the session with NORTHERN DRILLING rising 5.66% to €28.00 on Tuesday, after two successive sessions in a row of losses. Oslo Børs Benchmark Index_GI rose 0.1% to €1,301.38, following the last session’s downward trend on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, NORTHERN DRILLING has a trailing twelve months EPS of kr-5.96.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.22%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, NORTHERN DRILLING’s stock is considered to be overbought (>=80).

Volume

Today’s last reported volume for NORTHERN DRILLING is 2842 which is 77.32% below its average volume of 12531.

Yearly Top and Bottom Value

NORTHERN DRILLING’s stock is valued at kr28.00 at 22:40 EST, way below its 52-week high of kr35.90 and way higher than its 52-week low of kr21.00.

Moving Average

NORTHERN DRILLING’s value is above its 50-day moving average of kr26.21 and below its 200-day moving average of kr29.11.

More news about NORTHERN DRILLING.

9. ULTIMOVACS (ULTI.OL)

5.63% Price Change

Ultimovacs ASA, a biotech company, develops immunotherapies against cancers. Its lead product candidate is UV1, a peptide-based cancer vaccine that induces a specific T cell response against the universal cancer antigen telomerase. The company was incorporated in 2011 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with ULTIMOVACS rising 5.63% to €76.90 on Tuesday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI rose 0.1% to €1,301.38, following the last session’s downward trend on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, ULTIMOVACS has a trailing twelve months EPS of kr-5.57.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -40.11%.

Moving Average

ULTIMOVACS’s value is above its 50-day moving average of kr75.42 and way under its 200-day moving average of kr104.04.

Yearly Top and Bottom Value

ULTIMOVACS’s stock is valued at kr76.90 at 22:40 EST, way under its 52-week high of kr142.60 and way above its 52-week low of kr58.50.

More news about ULTIMOVACS.

10. SOLSTAD OFFSHORE (SOFF.OL)

5.35% Price Change

Solstad Offshore ASA operates offshore service vessels and maritime services to offshore energy industry. It owns and operates platform supply vessel, anchor handling tug support vessel, and construction service vessels. The company offers subsea construction and renewable energy services, such as geotechnical work, walk to work services, grouting, SURF operations, cable laying and repair, trenching and burial, ROV support, installation of subsea equipment, survey work, IMR operations, node seismic operations, and diving and topside maintenance work. It operates a fleet of 27 construction service vessels, 20 anchor handling tug support vessels, and 39 platform supply vessels. The company was founded in 1964 and is headquartered in Skudeneshavn, Norway.

Oslo Børs Benchmark Index_GI ended the session with SOLSTAD OFFSHORE rising 5.35% to €26.00 on Tuesday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI jumped 0.1% to €1,301.38, following the last session’s downward trend on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, SOLSTAD OFFSHORE has a trailing twelve months EPS of kr-3.17.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -14.43%.

More news about SOLSTAD OFFSHORE.

Losers Today

1. ADOCIA (ADOC.PA)

-12.69% Price Change

Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Its proprietary BioChaperone technological platform provides molecular delivery of therapeutic proteins. The company's clinical product pipeline includes insulin formulations, such as BioChaperone Lispro U100 and U200, which are ultra-rapid formulations based on rapid insulin lispro; BioChaperone Combo, a combination of acting insulin glargine and rapid-acting insulin lispro; BioChaperone LisPram, a combination of prandial insulin with pramlintide; and BioChaperone Glucagon, an aqueous formulation of human glucagon for the treatment of hypoglycemia, as well as M1Pram, a metabolite of insulin glargine and pramlintide. Its preclinical pipeline includes products for the treatment of diabetes and obesity comprising AdoShell Islets, an implant containing islets of Langerhans; AdOral Sema, an oral delivery of semaglutide; and BioChaperone GluExe, a combination of glucagon and exenatide. The company has a strategic alliance with Tonghua Dongbao Pharmaceutical Co., Ltd. to develop and commercialize BioChaperone Lispro and BioChaperone Combo in China and other Asian and Middle Eastern territories. Adocia SA was incorporated in 2005 and is headquartered in Lyon, France.

CAC 40 ended the session with ADOCIA dropping 12.69% to €7.91 on Tuesday, after two consecutive sessions in a row of losses. CAC 40 jumped 0.08% to €7,282.12, following the last session’s downward trend on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, ADOCIA has a trailing twelve months EPS of €-0.87.

Yearly Top and Bottom Value

ADOCIA’s stock is valued at €7.91 at 22:40 EST, way above its 52-week high of €6.62.

More news about ADOCIA.

2. VALUE8 CUM PREF (PREVA.AS)

-9.8% Price Change

Value8 N.V. is a private equity firm specializing in growth capital investments in small and medium-sized companies. The firm primarily invests in the food, healthcare, business and financial services, energy, safety and security, water and environment, leisure, luxury products and internet sectors. It typically invests in Western Europe, primarily in the Netherlands, Belgium and France. The firm considers investments in companies with an enterprise value between €5 million ($6.96 million) and €150 million ($208.87 million). The firm prefers to take a seat on the board of directors and seeks to exit the investment through a public listing. Value8 NV was founded in 2008 and is headquartered in Bussum, the Netherlands.

AEX-Index ended the session with VALUE8 CUM PREF falling 9.8% to €4.42 on Tuesday, after five successive sessions in a row of losses. AEX-Index slid 0.13% to €734.93, after two consecutive sessions in a row of losses, on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, VALUE8 CUM PREF has a trailing twelve months EPS of €1.869.

PE Ratio

VALUE8 CUM PREF has a trailing twelve months price to earnings ratio of 2.36. Meaning, the purchaser of the share is investing €2.36 for every euro of annual earnings.

More news about VALUE8 CUM PREF.

3. ATLANTIC SAPPHIRE (ASA.OL)

-9.5% Price Change

Atlantic Sapphire ASA, together with its subsidiaries, engages in the land-based salmon farming business. It operates through two segments, Fish Farming (Denmark); and Fish Farming (US). The company is involved in the production and sale of salmon. It operates in the United States, Denmark, and internationally. The company was founded in 2010 and is headquartered in Vikebukt, Norway.

Oslo Børs Benchmark Index_GI ended the session with ATLANTIC SAPPHIRE dropping 9.5% to €1.81 on Tuesday, after two consecutive sessions in a row of gains. Oslo Børs Benchmark Index_GI rose 0.1% to €1,301.38, following the last session’s downward trend on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, ATLANTIC SAPPHIRE has a trailing twelve months EPS of kr-7.8.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.26%.

Volume

Today’s last reported volume for ATLANTIC SAPPHIRE is 2209080 which is 249.41% above its average volume of 632228.

More news about ATLANTIC SAPPHIRE.

4. ONWARD MEDICAL (ONWD.BR)

-8.8% Price Change

Onward Medical N.V., a medical technology company, focuses on developing therapies for spinal cord injuries in the Netherlands and internationally. The company engages in developing ARC-EX, an external non-invasive platform that consists of a wearable stimulator and wireless programmer; and ARCIM, an implantable platform, which consists of an implantable pulse generator and lead that is placed near the spinal cord. It also engages in developing Up-LIFT Trial to evaluate the safety and effectiveness of non-invasive electrical spinal cord stimulation to treat upper extremity functional deficits with chronic tetraplegia. The company was founded in 2014 and is headquartered in Eindhoven, Netherlands.

BEL 20 ended the session with ONWARD MEDICAL falling 8.8% to €3.73 on Tuesday while BEL 20 jumped 0.1% to €3,677.75.

Earnings Per Share

As for profitability, ONWARD MEDICAL has a trailing twelve months EPS of €-1.2.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -48.44%.

Yearly Top and Bottom Value

ONWARD MEDICAL’s stock is valued at €3.73 at 22:40 EST, way under its 52-week high of €7.10 and higher than its 52-week low of €3.71.

Moving Average

ONWARD MEDICAL’s worth is way under its 50-day moving average of €4.78 and way below its 200-day moving average of €5.23.

More news about ONWARD MEDICAL.

5. NAPATECH (NAPA.OL)

-7.41% Price Change

Napatech A/S offers reconfigurable computing solutions for the networking and cybersecurity applications worldwide. The company provides Link Capture Software that enables packet capture with nanosecond timestamping and replay with precise inter-frame gap control; Link Inline Software, which offers a processing architecture that offloads and accelerates flow aware application data planes; Link Virtualization Software that offloads and accelerates the Open vSwitch data plane to enhance CPU efficiency and network performance; and Link Programmable, which enables end users and OEMs to deploy FPGA computation solutions. It also offers solutions for telecom operators, cloud and data center service providers, and infrastructure and defense, as well as financial services, cyber security, network management, and virtualization. The company was incorporated in 2003 and is headquartered in Copenhagen, Denmark.

Oslo Børs Benchmark Index_GI ended the session with NAPATECH sliding 7.41% to €10.00 on Tuesday, after three consecutive sessions in a row of gains. Oslo Børs Benchmark Index_GI rose 0.1% to €1,301.38, following the last session’s downward trend on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, NAPATECH has a trailing twelve months EPS of kr-1.21.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -57.61%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, NAPATECH’s stock is considered to be oversold (<=20).

Sales Growth

NAPATECH’s sales growth for the current quarter is negative 35.7%.

Yearly Top and Bottom Value

NAPATECH’s stock is valued at kr10.00 at 22:40 EST, way below its 52-week high of kr15.70 and way above its 52-week low of kr8.70.

More news about NAPATECH.

6. AFFLUENT MEDICAL (AFME.PA)

-5.6% Price Change

Affluent Medical SA develops minimally invasive medical devices for the treatment of heart and vascular diseases in France. It develops Kardiozis technology for the treatment of abdominal aortic aneurysm; Kalios and Epygon implants to treat mitral insufficiency; and Artus implant, an implantable electro-mechanical artificial sphincter for the treatment of severe urinary incontinence in women and men. The company was founded in 2011 and is based in Aix-en-Provence, France.

CAC 40 ended the session with AFFLUENT MEDICAL sliding 5.6% to €1.18 on Tuesday, after two successive sessions in a row of losses. CAC 40 rose 0.08% to €7,282.12, following the last session’s downward trend on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, AFFLUENT MEDICAL has a trailing twelve months EPS of €-0.58.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -39.36%.

Yearly Top and Bottom Value

AFFLUENT MEDICAL’s stock is valued at €1.18 at 22:40 EST, way below its 52-week high of €3.28 and higher than its 52-week low of €1.10.

More news about AFFLUENT MEDICAL.

7. CABKA (CABKA.AS)

-5.57% Price Change

Cabka N.V. manufactures and sells pallets and containers made from recycled plastic in Europe and North America. The company sells its recycled plastic products to blue chip clients in the food and beverage, retail, automotive, dairy, meat and poultry, chemical, pharmaceutical, and pooling industries in approximately 80 countries. Cabka N.V. was incorporated in 1994 and is headquartered in Berlin, Germany.

AEX-Index ended the session with CABKA sliding 5.57% to €7.46 on Tuesday, following the last session’s upward trend. AEX-Index fell 0.13% to €734.93, after two consecutive sessions in a row of losses, on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, CABKA has a trailing twelve months EPS of €-1.15.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -37.67%.

More news about CABKA.

8. ALD (ALD.PA)

-5.32% Price Change

ALD S.A. provides service leasing and vehicle fleet management services. Its products and services include full service leasing, fleet management, outsourcing solutions, and sale and lease back; fleet consultancy; and tools and services for fleet managers and drivers. The company is also involved in trading used cars and light commercial vehicles, and the retail sale of vehicles. The company operates in Western Europe, Central and Eastern Europe, Northern Europe, South America, Africa, and Asia. ALD S.A. was founded in 1946 and is based in Rueil-Malmaison, France. ALD S.A. operates as a subsidiary of Société Générale Société anonyme.

CAC 40 ended the session with ALD dropping 5.32% to €8.01 on Tuesday, after two successive sessions in a row of losses. CAC 40 rose 0.08% to €7,282.12, following the last session’s downward trend on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, ALD has a trailing twelve months EPS of €2.33.

PE Ratio

ALD has a trailing twelve months price to earnings ratio of 3.44. Meaning, the purchaser of the share is investing €3.44 for every euro of annual earnings.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ALD’s stock is considered to be overbought (>=80).

Volume

Today’s last reported volume for ALD is 1654700 which is 201.68% above its average volume of 548495.

More news about ALD.

9. MOREFIELD GROUP (MORE.AS)

-4.76% Price Change

Morefield Group N.V. through its subsidiary Kersten Groep BV, engages in the selecting, advising, supplying, and maintaining medical aids for physical disability peoples. The company manufactures orthoses, such as braces and splints. It serves to municipalities, care administration offices, health insurers, and care institutions/care organizations. The company was formerly known as HeadFirst Source Group N.V. and changed its name to Morefield Group N.V. in January 2019. Morefield Group N.V. was incorporated in 1983 and is headquartered in Willemstad, Curaçao.

AEX-Index ended the session with MOREFIELD GROUP falling 4.76% to €0.32 on Tuesday while AEX-Index fell 0.13% to €734.93.

Earnings Per Share

As for profitability, MOREFIELD GROUP has a trailing twelve months EPS of €0.1.

PE Ratio

MOREFIELD GROUP has a trailing twelve months price to earnings ratio of 3.2. Meaning, the purchaser of the share is investing €3.2 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 29.06%.

Moving Average

MOREFIELD GROUP’s worth is higher than its 50-day moving average of €0.31 and higher than its 200-day moving average of €0.30.

Volume

Today’s last reported volume for MOREFIELD GROUP is 24073 which is 141.28% above its average volume of 9977.

More news about MOREFIELD GROUP.

10. EQVA (EQVA.OL)

-4.73% Price Change

Eqva ASA, a knowledge-based maritime company, primarily engages in the shipbuilding business worldwide. It operates in two segments, Shipbuilding Technology and Other. The company provides newbuilding, rebuilding, and service assignments on vessels for offshore oil production, renewable energy production, fishing, and fish farming for ship owners. It delivers technology for customers within the seafood, energy, and transport sectors. The company was formerly known as Havyard Group ASA and changed its name to Eqva ASA in November 2022. Eqva ASA was founded in 1999 and is headquartered in Fosnavåg, Norway.

Oslo Børs Benchmark Index_GI ended the session with EQVA sliding 4.73% to €2.82 on Tuesday, after three consecutive sessions in a row of gains. Oslo Børs Benchmark Index_GI jumped 0.1% to €1,301.38, following the last session’s downward trend on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, EQVA has a trailing twelve months EPS of kr-0.32.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -5.45%.

Volatility

EQVA’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.09%, a negative 0.07%, and a positive 3.12%.

EQVA’s highest amplitude of average volatility was 0.95% (last week), 2.80% (last month), and 3.12% (last quarter).

Revenue Growth

Year-on-year quarterly revenue growth grew by 209.8%, now sitting on 594.65M for the twelve trailing months.

Volume

Today’s last reported volume for EQVA is 4950 which is 61.77% below its average volume of 12949.

Moving Average

EQVA’s worth is under its 50-day moving average of kr2.92 and under its 200-day moving average of kr3.07.

More news about EQVA.

Stay up to date with our winners and losers daily report